ID NBR1_MOUSE Reviewed; 988 AA. AC P97432; Q9JIH9; DT 30-MAY-2000, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-1997, sequence version 1. DT 02-SEP-2026, entry version 182. DE RecName: Full=Next to BRCA1 gene 1 protein; DE AltName: Full=Membrane component chromosome 17 surface marker 2 homolog; DE AltName: Full=Neighbor of BRCA1 gene 1 protein; GN Name=Nbr1; Synonyms=M17s2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=ICR; TISSUE=Brain; RX PubMed=8975707; DOI=10.1006/geno.1996.0633; RA Chambers J.A., Solomon E.; RT "Isolation of the murine Nbr1 gene adjacent to the murine Brca1 gene."; RL Genomics 38:305-313(1996). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=129/Sv; TISSUE=Testis; RX PubMed=11179671; DOI=10.1016/s0378-1119(00)00549-7; RA Dimitrov S., Brennerova M., Forejt J.; RT "Expression profiles and intergenic structure of head-to-head oriented RT Brca1 and Nbr1 genes."; RL Gene 262:89-98(2001). RN [3] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Pancreas; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [4] RP FUNCTION, DISRUPTION PHENOTYPE, SUBCELLULAR LOCATION, INDUCTION BY RP OXIDATIVE STRESS, AND INTERACTION WITH SQSTM1. RX PubMed=31916398; DOI=10.15252/embr.201948902; RA Sanchez-Martin P., Sou Y.S., Kageyama S., Koike M., Waguri S., Komatsu M.; RT "NBR1-mediated p62-liquid droplets enhance the Keap1-Nrf2 system."; RL EMBO Rep. 21:e48902-e48902(2020). RN [5] RP FUNCTION, AND INTERACTION WITH IL12A AND IL12B. RX PubMed=34374750; DOI=10.1093/ecco-jcc/jjab144; RA Merkley S.D., Goodfellow S.M., Guo Y., Wilton Z.E.R., Byrum J.R., RA Schwalm K.C., Dinwiddie D.L., Gullapalli R.R., Deretic V., RA Jimenez Hernandez A., Bradfute S.B., In J.G., Castillo E.F.; RT "Non-autophagy Role of Atg5 and NBR1 in Unconventional Secretion of IL-12 RT Prevents Gut Dysbiosis and Inflammation."; RL J. Crohns. Colitis. 16:259-274(2022). CC -!- FUNCTION: Ubiquitin-binding autophagy adapter that participates in CC different processes including host defense or intracellular homeostasis CC (PubMed:31916398, PubMed:34374750). Possesses a double function during CC the selective autophagy by acting as a shuttle bringing ubiquitinated CC proteins to autophagosomes and also by participating in the formation CC of protein aggregates. Plays a role in the regulation of the innate CC immune response by modulating type I interferon production and CC targeting ubiquitinated IRF3 for autophagic degradation (By CC similarity). In response to oxidative stress, promotes an increase in CC SQSTM1 levels, phosphorylation, and body formation by preventing its CC autophagic degradation (PubMed:31916398). In turn, activates the KEAP1- CC NRF2/NFE2L2 antioxidant pathway (PubMed:31916398). Also plays non- CC autophagy role by mediating the shuttle of IL-12 to late endosome for CC subsequent secretion (PubMed:34374750). {ECO:0000250|UniProtKB:Q14596, CC ECO:0000269|PubMed:31916398, ECO:0000269|PubMed:34374750}. CC -!- SUBUNIT: Homooligomer and heterooligomer. Interacts with TRIM55 (By CC similarity). Interacts with titin/TTN (By similarity). Interacts with CC RNF29, USP8, MAP1LC3A, MAP1LC3B, MAP1LC3C, GABARAP, GABARAPL1 and CC GABARAPL2. Binds to ubiquitin and ubiquitinated proteins. Interacts CC with SQSTM1. Interacts with TAX1BP1. Interacts with IRF3; this CC interaction mediates autophagic degradation of IRF3 (By similarity). CC Interacts with IL12A and IL12B (PubMed:34374750). Interacts with SRBD1; CC this interaction clears SRBD1 through the autophagic-lysosomal pathway CC (By similarity). {ECO:0000250|UniProtKB:Q501R9, CC ECO:0000269|PubMed:34374750}. CC -!- INTERACTION: CC P97432; Q9GZQ8: MAP1LC3B; Xeno; NbExp=2; IntAct=EBI-642554, EBI-373144; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:31916398}. CC Cytoplasmic vesicle, autophagosome {ECO:0000250|UniProtKB:Q14596}. CC Lysosome {ECO:0000250|UniProtKB:Q14596}. Cytoplasm, myofibril, CC sarcomere, M line {ECO:0000250|UniProtKB:Q501R9}. Note=In cardiac CC muscles localizes to the sarcomeric M line (By similarity). Is targeted CC to lysosomes for degradation (By similarity). CC {ECO:0000250|UniProtKB:Q14596, ECO:0000250|UniProtKB:Q501R9, CC ECO:0000269|PubMed:31916398}. CC -!- TISSUE SPECIFICITY: Expressed in brain. CC -!- INDUCTION: In response to oxidative stress. CC {ECO:0000269|PubMed:31916398}. CC -!- DOMAIN: The PB1 domain mediates interaction with SQSTM1. {ECO:0000250}. CC -!- PTM: Phosphorylated by GSK3A; this phosphorylation inhibits NBR1 CC involvement in the formation of ubiquitinated protein aggregates. CC {ECO:0000250|UniProtKB:Q14596}. CC -!- DISRUPTION PHENOTYPE: NBR1-conditional knockout mice are not affected CC concerning general autophagy. However, the deletion results in a slight CC but significant reduction on the number and size of SQSTM1 liquid CC droplets. {ECO:0000269|PubMed:34374750}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U73039; AAC53025.1; -; mRNA. DR EMBL; AF227188; AAF74118.1; -; mRNA. DR CCDS; CCDS25475.1; -. DR RefSeq; NP_001239149.1; NM_001252220.1. DR RefSeq; NP_032702.1; NM_008676.3. DR AlphaFoldDB; P97432; -. DR SMR; P97432; -. DR BioGRID; 201698; 17. DR FunCoup; P97432; 3281. DR IntAct; P97432; 8. DR MINT; P97432; -. DR STRING; 10090.ENSMUSP00000099388; -. DR iPTMnet; P97432; -. DR PhosphoSitePlus; P97432; -. DR PaxDb; 10090-ENSMUSP00000099388; -. DR ProteomicsDB; 252646; -. DR Pumba; P97432; -. DR Antibodypedia; 8116; 316 antibodies from 35 providers. DR DNASU; 17966; -. DR Ensembl; ENSMUST00000103098.9; ENSMUSP00000099387.3; ENSMUSG00000017119.21. DR Ensembl; ENSMUST00000103099.8; ENSMUSP00000099388.2; ENSMUSG00000017119.21. DR Ensembl; ENSMUST00000107218.10; ENSMUSP00000102836.4; ENSMUSG00000017119.21. DR GeneID; 17966; -. DR KEGG; mmu:17966; -. DR UCSC; uc007lpg.2; mouse. DR AGR; MGI:108498; -. DR CTD; 4077; -. DR MGI; MGI:108498; Nbr1. DR VEuPathDB; HostDB:ENSMUSG00000017119; -. DR eggNOG; KOG4351; Eukaryota. DR eggNOG; KOG4582; Eukaryota. DR GeneTree; ENSGT00390000016335; -. DR InParanoid; P97432; -. DR OMA; SHWRLTQ; -. DR OrthoDB; 661148at2759; -. DR PhylomeDB; P97432; -. DR Reactome; R-MMU-9664873; Pexophagy. DR BioGRID-ORCS; 17966; 12 hits in 76 CRISPR screens. DR PRO; PR:P97432; -. DR Proteomes; UP000000589; Chromosome 11. DR RNAct; P97432; protein. DR Bgee; ENSMUSG00000017119; Expressed in ciliary body and 267 other cell types or tissues. DR ExpressionAtlas; P97432; baseline and differential. DR GO; GO:0005776; C:autophagosome; IEA:UniProtKB-SubCell. DR GO; GO:0005737; C:cytoplasm; EXP:UniProtKB. DR GO; GO:0005829; C:cytosol; ISS:UniProtKB. DR GO; GO:0005770; C:late endosome; IDA:UniProtKB. DR GO; GO:0005764; C:lysosome; ISS:UniProtKB. DR GO; GO:0031430; C:M band; IEA:UniProtKB-SubCell. DR GO; GO:0005758; C:mitochondrial intermembrane space; IDA:MGI. DR GO; GO:0016604; C:nuclear body; ISO:GO_Central. DR GO; GO:0005654; C:nucleoplasm; ISO:GO_Central. DR GO; GO:0005778; C:peroxisomal membrane; TAS:Reactome. DR GO; GO:0000407; C:phagophore assembly site; IDA:MGI. DR GO; GO:0043235; C:signaling receptor complex; ISS:UniProtKB. DR GO; GO:0051019; F:mitogen-activated protein kinase binding; IDA:BHF-UCL. DR GO; GO:0043130; F:ubiquitin binding; ISS:UniProtKB. DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro. DR GO; GO:0016236; P:macroautophagy; ISS:UniProtKB. DR GO; GO:0045668; P:negative regulation of osteoblast differentiation; IMP:BHF-UCL. DR GO; GO:0030500; P:regulation of bone mineralization; IMP:BHF-UCL. DR GO; GO:0032872; P:regulation of stress-activated MAPK cascade; IMP:BHF-UCL. DR CDD; cd14947; NBR1_like; 1. DR CDD; cd06396; PB1_NBR1; 1. DR CDD; cd14319; UBA_NBR1; 1. DR CDD; cd02340; ZZ_NBR1_like; 1. DR FunFam; 1.10.8.10:FF:000033; Next to BRCA1 gene 1 protein; 1. DR FunFam; 3.10.20.90:FF:000292; Next to BRCA1 gene 1 protein; 1. DR FunFam; 3.30.60.90:FF:000007; Next to BRCA1 gene 1 protein; 1. DR FunFam; 2.60.40.10:FF:000199; next to BRCA1 gene 1 protein-like; 1. DR Gene3D; 3.30.60.90; -; 1. DR Gene3D; 1.10.8.10; DNA helicase RuvA subunit, C-terminal domain; 1. DR Gene3D; 2.60.40.10; Immunoglobulins; 1. DR Gene3D; 3.10.20.90; Phosphatidylinositol 3-kinase Catalytic Subunit, Chain A, domain 1; 1. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR032350; Nbr1_FW. DR InterPro; IPR053793; PB1-like. DR InterPro; IPR000270; PB1_dom. DR InterPro; IPR034852; PB1_Nbr1. DR InterPro; IPR015940; UBA. DR InterPro; IPR009060; UBA-like_sf. DR InterPro; IPR056893; UBA_Nbr1_C. DR InterPro; IPR000433; Znf_ZZ. DR InterPro; IPR043145; Znf_ZZ_sf. DR PANTHER; PTHR20930:SF2; NEXT TO BRCA1 GENE 1 PROTEIN; 1. DR PANTHER; PTHR20930; OVARIAN CARCINOMA ANTIGEN CA125-RELATED; 1. DR Pfam; PF16158; N_BRCA1_IG; 1. DR Pfam; PF00564; PB1; 1. DR Pfam; PF24932; UBA_NBR1_C; 1. DR Pfam; PF00569; ZZ; 1. DR SMART; SM00666; PB1; 1. DR SMART; SM00291; ZnF_ZZ; 1. DR SUPFAM; SSF54277; CAD & PB1 domains; 1. DR SUPFAM; SSF57850; RING/U-box; 1. DR SUPFAM; SSF46934; UBA-like; 1. DR PROSITE; PS51745; PB1; 1. DR PROSITE; PS50030; UBA; 1. DR PROSITE; PS01357; ZF_ZZ_1; 1. DR PROSITE; PS50135; ZF_ZZ_2; 1. PE 1: Evidence at protein level; KW Cytoplasm; Cytoplasmic vesicle; Lysosome; Metal-binding; Phosphoprotein; KW Reference proteome; Ubl conjugation; Zinc; Zinc-finger. FT CHAIN 1..988 FT /note="Next to BRCA1 gene 1 protein" FT /id="PRO_0000096747" FT DOMAIN 4..86 FT /note="PB1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01081" FT DOMAIN 935..979 FT /note="UBA" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00212" FT ZN_FING 213..265 FT /note="ZZ-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00228" FT REGION 126..150 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 543..637 FT /note="ATG8 family proteins-binding" FT /evidence="ECO:0000250" FT REGION 611..644 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 745..756 FT /note="ATG8 family proteins-binding" FT /evidence="ECO:0000250" FT REGION 768..822 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 841..900 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 795..807 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 808..822 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 218 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00228" FT BINDING 221 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00228" FT BINDING 232 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00228" FT BINDING 235 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00228" FT BINDING 241 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00228" FT BINDING 244 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00228" FT BINDING 251 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00228" FT BINDING 255 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00228" FT MOD_RES 117 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q14596" FT MOD_RES 587 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q14596" FT MOD_RES 591 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q501R9" FT MOD_RES 597 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q501R9" FT MOD_RES 626 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q14596" FT MOD_RES 860 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q501R9" FT CONFLICT 807 FT /note="Q -> R (in Ref. 2; AAF74118)" FT /evidence="ECO:0000305" SQ SEQUENCE 988 AA; 109958 MW; E5BB4B281FE33CE0 CRC64; MEPQVTLNVT FKNETQSFLV SDPENTTWAD VEAMVKVSFD LNTIQIKYLD EENEEISINS QGEYEEALKM ANIKQGNQLQ MQVHEGYHVV DEALPKNVVE NQAAARTGKK PLAHYSSLVR VLGSDMKTTE EPAPEQCSSA PCDTDQPQDK PPDWFTSYLE MFREQVVKET VEKLEQRLQE KLVLQKPLLS SSPTEVSMPI SEETLFLPEN QFSWHIACSH CQKRIVGVRY QCSLCPSYNI CEDCEAGPYT HDTNHVLLKL RRPVVISSEP FFYSKYSAPR LPAALEQVRL QKQVDKNFVK AEKQRLRAEK KQRKAEVKEL KKQLKLHRKI HLWNSIHGLQ SPKSPLGRPE SLLQSNTLML PLQPCAPVMP TLSAAFVDEN LPDGTHLQPG TKFIKHWRMK NTGNVKWNTD TKLKFMWGNL TLASTEKKDV LVPCLKAGHV GVVSVEFIAP TLEGTYTSHW RLSHKGQQFG PRVWCSIIVD PFPSSESPDN VEGDRISSSK ADDFSCEQEE AFLLAEEEIP LGEVTKQTEG TGASASQKTR RAASERELYI PSVDLLTAQD LLSFELLDIN IVQELERVPH NTPVDMTPCM SPLPHDSPLI EKPGLGQIQE ESEGAGFKAP PDSTVSAKRK AETPASVEET EEDLSGTQFV CETVIRSLTL DAAPDHNPPC RQRSPQRELQ LYSTEGQQPL VLPGFCRKDS SLKFALPEEG PRGDEREEIV HIVEEEVVEE EEEVQDEEVQ SQSSASSEDY IIILPECFDT SRPLGDSMYS SALSQPGLER GAEGEPGIES GLEPTEARER LPERESQPQE QSISDILTTS QPLDTVPLVP EVAGLPAALS RSAPCGQCES SGVDSPGVDS PATMHEVPPA PDDIRGEPRG STGLANSRQR SCDHSRHHNG SSIAGGLVKG ALSVAASAYK ALFSGPPVTA QPIVSEDQTT ALMAHLFEMG FCDRQLNLRL LRKHNYNILQ VVTELLQVNN NDWYSHRY //